Defective neuronal sprouting by human apolipoprotein E4 is a gain‐of‐negative function

The apolipoprotein E (apoE) epsilon 4 allele (apoE4) is a major risk factor for neurodegenerative conditions, including Alzheimer's disease (AD). A role for apoE in regeneration of synaptic circuitry after neural injury has been shown in several in vitro studies in which apoE3 supports neuronal sprouting better than apoE4. We evaluated sprouting in an in vitro mouse organotypic hippocampal slice culture system derived from transgenic mice expressing apoE3 or apoE4, in which apoE‐dependent granule cell mossy fiber sprouting in the presence of apoE4 is only 51% of the level of apoE3. Sprouting supported by apoE4 had a dose response opposite that by supported by apoE3: although increasing E3 expression increased sprouting, increasing E4 expression decreased sprouting, suggesting that the defect in E4 in supporting neuronal sprouting is a gain‐of‐negative activity. These results may have important pharmacogenomic implications for AD therapies that modulate apoE expression levels. © 2002 Wiley‐Liss, Inc.

[1]  R. Greenberg Biometry , 1969, The Yale Journal of Biology and Medicine.

[2]  B. Gähwiler,et al.  Growth of hippocampal mossy fibers: A lesion and coculture study of organotypic slice cultures , 1987, The Journal of comparative neurology.

[3]  K. Weisgraber Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. , 1990, Journal of lipid research.

[4]  D. Muller,et al.  A simple method for organotypic cultures of nervous tissue , 1991, Journal of Neuroscience Methods.

[5]  N. Maeda,et al.  Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[6]  G. Handelmann,et al.  Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro. , 1992, Journal of lipid research.

[7]  J. Poirier Apolipoprotein E in animal models of CNS injury and in alzheimer's disease , 1994, Trends in Neurosciences.

[8]  M. J. Castiñeiras,et al.  An enzyme-linked immunosorbent assay method to measure human apolipoprotein E levels using commercially available reagents: effect of apolipoprotein E polymorphism on serum apolipoprotein E concentration. , 1994, Analytical biochemistry.

[9]  R. Mahley,et al.  Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. , 1994, Science.

[10]  K. Weisgraber Apolipoprotein E: structure-function relationships. , 1994, Advances in protein chemistry.

[11]  F. Dudek,et al.  Factors influencing mossy fiber collateral sprouting in organotypic slice cultures of neonatal mouse hippocampus , 1995, The Journal of comparative neurology.

[12]  E Brisch,et al.  The Inhibitory Effect of Apolipoprotein E4 on Neurite Outgrowth Is Associated with Microtubule Depolymerization (*) , 1995, The Journal of Biological Chemistry.

[13]  D. Holtzman,et al.  Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. Mahley,et al.  Stable Expression and Secretion of Apolipoproteins E3 and E4 in Mouse Neuroblastoma Cells Produces Differential Effects on Neurite Outgrowth (*) , 1995, The Journal of Biological Chemistry.

[15]  W. Strittmatter,et al.  Interaction of Apolipoprotein E with Laminin Increases Neuronal Adhesion and Alters Neurite Morphology , 1995, Experimental Neurology.

[16]  J. Gilbert,et al.  Human Apolipoprotein E2, E3, and E4 Isoform-Specific Transgenic Mice: Human-like Pattern of GlialandNeuronal Immunoreactivity in Central Nervous System Not Observed in Wild-Type Mice , 1996, Neurobiology of Disease.

[17]  315 Estrogen, apolipoprotein E and the risk of Alzheimer's Disease , 1996, Neurobiology of Aging.

[18]  M. Tolar,et al.  A thrombin cleavage fragment of apolipoprotein E exhibits isoform-specific neurotoxicity. , 1996, Neuroreport.

[19]  Jonathan D. Smith,et al.  Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides , 1996, Nature Genetics.

[20]  A. Fagan,et al.  Apolipoprotein E-containing High Density Lipoprotein Promotes Neurite Outgrowth and Is a Ligand for the Low Density Lipoprotein Receptor-related Protein* , 1996, The Journal of Biological Chemistry.

[21]  T. Morgan,et al.  Astrocytes and Microglia Respond to Estrogen with Increased apoE mRNAin Vivoandin Vitro , 1997, Experimental Neurology.

[22]  G. Getz,et al.  Effect of Apolipoprotein E on Neurite Outgrowth and β‐Amyloid‐Induced Toxicity in Developing Rat Primary Hippocampal Cultures , 1997, Journal of neurochemistry.

[23]  L. Schneider,et al.  Combined Tacrine and Estrogen Replacement Therapy in Patients with Alzheimer's Disease a, b , 1997, Annals of the New York Academy of Sciences.

[24]  R. Demattos,et al.  A Minimally Lipidated Form of Cell-derived Apolipoprotein E Exhibits Isoform-specific Stimulation of Neurite Outgrowth in the Absence of Exogenous Lipids or Lipoproteins* , 1998, The Journal of Biological Chemistry.

[25]  A. Fagan,et al.  Glial Fibrillary Acidic Protein–Apolipoprotein E (apoE) Transgenic Mice: Astrocyte-Specific Expression and Differing Biological Effects of Astrocyte-Secreted apoE3 and apoE4 Lipoproteins , 1998, The Journal of Neuroscience.

[26]  R. Mahley,et al.  Differential Cellular Accumulation/Retention of Apolipoprotein E Mediated by Cell Surface Heparan Sulfate Proteoglycans , 1998, The Journal of Biological Chemistry.

[27]  J. Gilbert,et al.  Regionally specific neuronal expression of human APOE gene in transgenic mice , 1998, Neuroscience Letters.

[28]  W. März,et al.  Apolipoprotein E Isoforms Increase Intracellular Ca2+ Differentially Through a ω‐Agatoxin IVa‐Sensitive Ca2+‐Channel , 1998, Brain pathology.

[29]  J. Gilbert,et al.  Cis-Acting Human ApoE Tissue Expression Element is Associated with Human Pattern of Intraneuronal ApoE in Transgenic Mice , 1998, Neurobiology of Aging.

[30]  L. Mucke,et al.  Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[31]  T. Morgan,et al.  Increased Synaptic Sprouting in Response to Estrogen via an Apolipoprotein E-Dependent Mechanism: Implications for Alzheimer’s Disease , 1998, The Journal of Neuroscience.

[32]  J. Gilbert,et al.  Specific regional transcription of apolipoprotein E in human brain neurons. , 1999, The American journal of pathology.

[33]  J. Poirier Apolipoprotein E: a pharmacogenetic target for the treatment of Alzheimer's disease. , 1999, Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology.

[34]  K. Ritchie,et al.  The current status of Apo E4 as a risk factor for Alzheimer's disease: an epidemiological perspective , 1999, International journal of geriatric psychiatry.

[35]  Y. Christen,et al.  Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype. , 1999, Free radical biology & medicine.

[36]  G. Cole,et al.  Methods for Evaluating a Slice Culture Model of Alzheimer’s Disease , 1999 .

[37]  M. Michikawa,et al.  Apolipoprotein E4 isoform-specific actions on neuronal cells in culture , 1999, Mechanisms of Ageing and Development.

[38]  B. Teter,et al.  Role of apolipoprotein E and estrogen in mossy fiber sprouting in hippocampal slice cultures , 1999, Neuroscience.

[39]  Matthias Orth,et al.  Expression of Human Apolipoprotein E3 or E4 in the Brains ofApoe−/− Mice: Isoform-Specific Effects on Neurodegeneration , 1999, The Journal of Neuroscience.

[40]  J. Gilbert,et al.  Human Apolipoprotein E Isoform‐Specific Differences in Neuronal Sprouting in Organotypic Hippocampal Culture , 1999, Journal of neurochemistry.

[41]  M. Mesulam Neuroplasticity Failure in Alzheimer's Disease Bridging the Gap between Plaques and Tangles , 1999, Neuron.

[42]  L. Kuller,et al.  Estrogen use, APOE, and cognitive decline , 2000, Neurology.

[43]  M. Mattson,et al.  A Mechanism for the Neuroprotective Effect of Apolipoprotein E , 2000, Journal of neurochemistry.

[44]  G. Siest,et al.  Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids. , 2000, Free radical biology & medicine.

[45]  A D Roses,et al.  The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection. , 2000, Biochimica et biophysica acta.

[46]  L. Mucke,et al.  Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease , 2000, Neuroscience.

[47]  Q. Fan,et al.  Apolipoprotein E Exhibits Isoform‐Specific Promotion of Lipid Efflux from Astrocytes and Neurons in Culture , 2000, Journal of neurochemistry.

[48]  T. Arendt Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization , 2001, Neuroscience.

[49]  C. Göritz,et al.  CNS synaptogenesis promoted by glia-derived cholesterol. , 2001, Science.

[50]  B. Teter,et al.  The presence of apoE4, not the absence of apoE3, contributes to AD pathology. , 2002, Journal of Alzheimer's disease : JAD.

[51]  Gregory J. Brewer,et al.  Apolipoprotein E4 inhibits, and apolipoprotein E3 promotes neurite outgrowth in cultured adult mouse cortical neurons through the low-density lipoprotein receptor-related protein , 2002, Brain Research.

[52]  Kaj Blennow,et al.  Measurement of Apolipoprotein E (apoE) in Cerebrospinal Fluid , 2000, Neurochemical Research.